These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7607229)

  • 21. Activation of DNA cleavage by dynemicin A in a B-Z conformational junction.
    Ichikawa A; Kuboya T; Aoyama T; Sugiura Y
    Biochemistry; 1992 Jul; 31(29):6784-7. PubMed ID: 1379070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis of elsamicin A, a novel antitumor antibiotic.
    Lam KS; Veitch JA; Forenza S; Combs CM; Colson KL
    J Nat Prod; 1989; 52(5):1015-21. PubMed ID: 2607345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
    Bachur NR; Johnson R; Yu F; Hickey R; Applegren N; Malkas L
    Mol Pharmacol; 1993 Nov; 44(5):1064-9. PubMed ID: 8246909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA.
    Hermann T; Westhof E
    J Mol Biol; 1998 Mar; 276(5):903-12. PubMed ID: 9566195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the sequential non-covalent and covalent interactions of the antitumour antibiotic hedamycin with double stranded DNA by NMR spectroscopy.
    Pavlopoulos S; Bicknell W; Wickham G; Craik DJ
    J Mol Recognit; 1999; 12(6):346-54. PubMed ID: 10611644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs.
    Hertzberg RP; Hecht SM; Reynolds VL; Molineux IJ; Hurley LH
    Biochemistry; 1986 Mar; 25(6):1249-58. PubMed ID: 3008824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove.
    Ikemoto N; Kumar RA; Ling TT; Ellestad GA; Danishefsky SJ; Patel DJ
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10506-10. PubMed ID: 7479829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrophobic DNA binding of esperamicin requires conformational distortion of the host DNA.
    Uesugi M; Kusakabe T; Sugiura Y
    Biochim Biophys Acta; 1995 Mar; 1261(1):99-106. PubMed ID: 7893766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gilvocarcin V exhibits both equilibrium DNA binding and UV light induced DNA adduct formation which is sequence context dependent.
    Knobler RM; Radlwimmer FB; Lane MJ
    Nucleic Acids Res; 1992 Sep; 20(17):4553-7. PubMed ID: 1408756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotics.
    Bailly C; Waring MJ
    Nucleic Acids Res; 1995 Mar; 23(6):885-92. PubMed ID: 7731800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organic synthesis and cell biology: partners in controlling gene expression.
    Halcomb RL
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9197-9. PubMed ID: 7937740
    [No Abstract]   [Full Text] [Related]  

  • 33. Anthracycline antibiotic arugomycin binds in both grooves of the DNA helix simultaneously: an NMR and molecular modelling study.
    Searle MS; Bicknell W; Wakelin LP; Denny WA
    Nucleic Acids Res; 1991 Jun; 19(11):2897-906. PubMed ID: 1647521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR investigation of the complexation of daunomycin with deoxytetranucleotides of different base sequence in aqueous solution.
    Davies DB; Eaton RJ; Baranovsky SF; Veselkov AN
    J Biomol Struct Dyn; 2000 Apr; 17(5):887-901. PubMed ID: 10798533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cleavage behavior of calicheamicin gamma 1 and calicheamicin T.
    Walker S; Landovitz R; Ding WD; Ellestad GA; Kahne D
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4608-12. PubMed ID: 1584797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
    Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T
    J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence specificity of quinoxaline antibiotics. 2. NMR studies of the binding of [N-MeCys3,N-MeCys7]TANDEM and triostin A to DNA containing a CpI step.
    Addess KJ; Feigon J
    Biochemistry; 1994 Oct; 33(41):12397-404. PubMed ID: 7918462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model of the interactions of calichemicin gamma 1 with a DNA fragment from pBR322.
    Hawley RC; Kiessling LL; Schreiber SL
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1105-9. PubMed ID: 2919161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ab initio calculations on (-)-calicheamicinone and some of its reactions involved in its activation and interaction with DNA.
    Rothchild R; Sapse AM; Balkova A; Lown JW
    J Biomol Struct Dyn; 2000 Dec; 18(3):413-21. PubMed ID: 11149517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
    Bailly C; Qu X; Anizon F; Prudhomme M; Riou JF; Chaires JB
    Mol Pharmacol; 1999 Feb; 55(2):377-85. PubMed ID: 9927631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.